Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Rising equities boost hedge fund performance; Barclay Hedge Fund Index up 2.38% in February

Monday, March 19, 2012
Opalesque Industry Update: Hedge funds gained 2.38% in February, according to the Barclay Hedge Fund Index compiled by BarclayHedge.

“Positive signs in the US housing and labor markets coupled with receding risk of a Greek default helped drive equity markets and the hedge funds that invest in them to another profitable month in February,” says Sol Waksman, founder and president of BarclayHedge.

“Eighty-eight percent of the hedge funds that have so far reported a February return have recorded a profit.”

The Barclay Emerging Markets Index was up 3.91% in February. Following a 5.06% gain in January, the Index has jumped 9.17% in the first two months of 2012.

“This is the strongest start for the Barclay Emerging Markets Index in 15 years,” says Waksman. “The previous best start was 17.53% in the first two months of 1997.”

Seventeen of the 18 indices tracked by BarclayHedge had gains in February. In addition to Emerging Markets, the Pacific Rim Equities Index was up 4.23%, Equity Long Bias gained 3.51%, European Equities were up 3.19%, and the Equity Long/Short Index added 2.23%.

The Equity Short Bias Index continues to plummet against rising equity markets. Short Bias traders lost 5.28% in February, and the Index is down 14.00% after just two months in 2012.

“Opportunities to make money selling stocks short are severely limited under current market conditions,” says Waksman.

The Barclay Fund of Funds Index was up 1.50% in February.

BarclayHedge

Press Release

BM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its